• Latest Posts

AAVantgarde closes €61M financing to move gene delivery program to the clinic

Italian life sciences fund hits €175M

Newron reports ‘striking’ schizophrenia study results 

Orbsen Therapeutics happy with interim diabetic kidney disease study results 

ADVERTISEMENT

Beyond Biotech podcast 28: Mainz Biomed, Newron Pharmaceuticals

Newron announces interim results from treatment-resistant schizophrenia trial

Watch: Interview with IRBM’s Heidi Kingdon Jones

Interview 14 Dec 2022

Sibylla Biotech: how physicists met biologists to discover new drugs

Partnership to deliver oncology workflow for 7 European hospitals

Chiesi marks start of Biotech Center of Excellence for the future of medicine in Parma

ADVERTISEMENT